Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 373 +23.00 (+6.57%) As of 01/21/2025 11:40 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Hemogenyx Pharmaceuticals Stock Price Performance 5 Day Performance+0.71%1 Month Performance+8.62%3 Month Performance+27,007.56%6 Month Performance+27,652.98%Year-To-Date Performance-7.21%1 Year Performance+13,533.04% Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HEMO Stock Chart for Wednesday, January, 22, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/21/2025GBX 350GBX 373+6.57%GBX 374.90GBX 350.103,838 shs£5.00 billion01/20/2025GBX 370.36GBX 350-5.50%GBX 374.90GBX 35014,178 shs£4.69 billion01/17/2025GBX 381.10GBX 370.36-2.82%GBX 378GBX 363.9714,056 shs£4.96 billion01/16/2025GBX 384GBX 381.10-0.76%GBX 400GBX 370.1011,585 shs£5.11 billion01/15/2025GBX 403.50GBX 384-4.83%GBX 384GBX 370.108,949 shs£5.15 billion01/14/2025GBX 382.23GBX 403.50+5.56%GBX 403.51GBX 375.106,890 shs£5.41 billion01/13/2025GBX 399.56GBX 382.23-4.34%GBX 399.25GBX 376.591,626 shs£5.12 billion01/10/2025GBX 400GBX 399.56-0.11%GBX 400GBX 3794,698 shs£5.35 billion01/09/2025GBX 399.75GBX 400+0.06%GBX 402.95GBX 3753,740 shs£5.36 billion01/08/2025GBX 395GBX 399.75+1.20%GBX 399.75GBX 3605,671 shs£5.36 billion Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/07/2025GBX 406.80GBX 395-2.90%GBX 420GBX 3902,561 shs£5.29 billion01/06/2025GBX 420GBX 406.80-3.14%GBX 418.50GBX 3957,520 shs£5.45 billion01/03/2025GBX 419.10GBX 420+0.21%GBX 420GBX 393.0730,225 shs£5.63 billion01/02/2025GBX 402GBX 419.10+4.25%GBX 419.10GBX 4124,215 shs£5.62 billion01/01/2025GBX 402GBX 402GBX 414.25GBX 4006,052 shs£5.39 billion12/31/2024GBX 420GBX 402-4.29%GBX 414.25GBX 4006,052 shs£5.39 billion12/30/2024GBX 391GBX 420+7.42%GBX 420GBX 392.108,157 shs£5.63 billion12/27/2024GBX 370GBX 391+5.68%GBX 391.95GBX 37013,419 shs£5.24 billion12/26/2024GBX 370GBX 370GBX 373.90GBX 358.8012,757 shs£4.96 billion12/25/2024GBX 370GBX 370GBX 373.90GBX 358.8012,757 shs£4.96 billion12/24/2024GBX 358.50GBX 370+3.21%GBX 373.90GBX 358.8012,757 shs£4.96 billion12/23/2024GBX 343.40GBX 358.50+4.40%GBX 358.50GBX 3337,935 shs£4.80 billion Related Companies Oxford Nanopore Technologies Stock Price Chart Genus Stock Price Chart Oxford Biomedica Stock Price Chart PureTech Health Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Avacta Group Stock Price Chart Bioventix Stock Price Chart 4basebio Stock Price Chart hVIVO Stock Price Chart Futura Medical Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HEMO Stock Alerts